deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT00304187

Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa

Effects of Erythromycin on Binge Eating and GI Function in Bulimia Nervosa

Sponsor: National Institute of Mental Health (NIMH)

Conditions Bulimia Nervosa Eating Disorders
Interventions Erythromycin Placebo
Updated 9 times since 2017 Last updated: Aug 16, 2018 Started: Sep 30, 2004 Primary completion: Nov 30, 2011 Completion: Nov 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00304187, this PHASE2 trial focuses on Bulimia Nervosa and Eating Disorders and remains completed. Sponsored by National Institute of Mental Health (NIMH), it has been updated 9 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotCompleted~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshotCompleted~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 4 earlier versions

  1. Sep 2018 — Jan 2021 [monthly]

    Completed PHASE2

  2. Jul 2018 — Sep 2018 [monthly]

    Completed PHASE2

  3. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE2

  4. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Mental Health (NIMH)
  • New York State Psychiatric Institute
Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations